Larimar Therapeutics
Price & Volume
Stats
See more52W Range | $3.19-$13.68 |
Market Cap | $403.8M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.15 |
News
See moreYahoo Finance • last year
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
Yahoo Finance • last year
Larimar Therapeutics to Present at the Guggenheim 5th Annual Inflammation, Neurology & Immunology Conference
Yahoo Finance • last year
Larimar Therapeutics Appoints Dr. Jeffery W. Sherman to its Board of Directors
Yahoo Finance • last year
Larimar Therapeutics to Present at the Citi 18th Annual BioPharma Conference
About
CEO | Dr. Carole S. Ben-Maimon M.D. |
CFO | Mr. Michael Celano CPA |
Address | Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 42 |
